Zura Bio (ZURA) Change in Cash (2022 - 2026)
Zura Bio's (ZURA) quarterly Change in Cash came in at $116.2 million in Q1 2026, up 2059.64% year-on-year from $5.4 million in Q1 2025, and up 492.39% quarter-over-quarter from -$29.6 million in Q4 2025.
Zura Bio (ZURA) Change in Cash (2022 - 2026) Analysis & Trends
Zura Bio's Change in Cash history runs 5 years deep, the most recent figure standing at $116.2 million for Q1 2026.
- On a quarterly basis, Change in Cash rose 2059.64% year-over-year to $116.2 million in Q1 2026; TTM through Mar 2026 was $55.0 million, a 31.86% decrease from a year earlier, with the FY2025 full-year figure at -$67.1 million, down 187.48% from the prior year.
- Change in Cash grew to $116.2 million in Q1 2026 per ZURA's latest filing, from -$29.6 million in the prior quarter.
- Across five years, Change in Cash topped out at $116.2 million in Q1 2026 and bottomed at -$29.6 million in Q4 2025.
- The 5-year median for Change in Cash is -$1.5 million (2022), against an average of $13.3 million.
- Across the five-year window, Change in Cash jumped 22450.32% in 2023 and slumped 6869.82% in 2025, its largest moves.
- Year by year, Change in Cash stood at -$1.5 million in 2022, then slumped by 173.48% to -$4.1 million in 2023, then plunged by 189.24% to -$11.7 million in 2024, then slumped by 152.58% to -$29.6 million in 2025, then soared by 492.39% to $116.2 million in 2026.
- Per Business Quant, the three latest ZURA Change in Cash figures stand at $116.2 million (Q1 2026), -$29.6 million (Q4 2025), and -$15.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 57.19 Mn |
| 10 | Zura Bio | 609.93 Mn | 609.93 Mn | - | 116.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116.19 Mn |
| Dec 31, 2025 | -29.61 Mn |
| Sep 30, 2025 | -15.47 Mn |
| Jun 30, 2025 | -16.08 Mn |
| Mar 31, 2025 | -5.93 Mn |
| Dec 31, 2024 | -11.72 Mn |
| Sep 30, 2024 | -222,000.00 |
| Jun 30, 2024 | 98.63 Mn |
| Mar 31, 2024 | -9.99 Mn |
| Dec 31, 2023 | -4.05 Mn |
| Sep 30, 2023 | -8.94 Mn |
| Jun 30, 2023 | 68.84 Mn |
| Mar 31, 2023 | 42.40 Mn |
| Dec 31, 2022 | -1.48 Mn |
| Sep 30, 2022 | -1.36 Mn |
| Jun 30, 2022 | -308,000.00 |
| Mar 31, 2022 | 4.72 Mn |